Skip to main content

Advertisement

SpringerLink
Log in

Meta-analyses in Cancer Clinical Trials: Principles and Pitfalls

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Glass GV. Primary, secondary, meta-analysis of research. Educat Res1976;5:3–8

    Article  Google Scholar 

  2. Pocock SJ, Lagakos SW. Practical experience of randomization in cancer trials: an international survey. Br J Cancer 1982;46:368

    PubMed  CAS  Google Scholar 

  3. Sacks HS, Barrier J, Reitman D, et al. Meta-analyses of randomized controlled trials. N Engl J Med 1987;316:450

    Article  PubMed  CAS  Google Scholar 

  4. Yates F, Cochran WG. The analysis of groups of patients. J R Stat Soc 1937;4:102–118

    Google Scholar 

  5. Chalmers TC, Matta RJ, Smith H, et al. Evidence favouring the use of anticoagulants in the hospital phase of acute myocardial infarction. N Engl J Med 1977;297:1091–1096

    Article  PubMed  CAS  Google Scholar 

  6. Fibrinolytic Therapy Trialists Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction. Lancet 1994;343:311

    Google Scholar 

  7. ISIS-1 (First International Study of Infarct Survival) Collaborative Group. A randomized trial of intravenous atenolol amongst 16,027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 1986;2:57–66

    Google Scholar 

  8. Peto R. Why do we need systematic overviews of randomized trials? Stat Med 1987;6:233–240

    PubMed  CAS  Google Scholar 

  9. Hennekens CH, Buring JE, Hebert PR. Implications of overviews of randomized trials. Stat Med 1987;6:397–402

    PubMed  CAS  Google Scholar 

  10. Chalmers TC, Leven H, Sacks HS, et al. Meta-analysis of clinical trials as a scientific discipline. I: control of bias and comparison with large co-operative trials. Stat Med 1987;6:315

    PubMed  CAS  Google Scholar 

  11. Peto R, Collins R, Gray R. Large-scale randomized evidence: large, simple trials and overviews of trials. Ann NY Acad Sci 1994;703:314

    Google Scholar 

  12. Kassirer JP. Clinical trials and meta-analysis. N Engl J Med 1992;327:273–274

    Article  PubMed  CAS  Google Scholar 

  13. Green S, Benedetti J, Crowley J. Clinical Trials in Oncology, Chapter 9, London, Chapman and Hall, 1997;167–182

    Google Scholar 

  14. Furberg CD, Morgan TM. Lessons from overviews of cardiovascular trials. Stat Med 1987;6:295

    PubMed  CAS  Google Scholar 

  15. Collins R. Discussion. Stat Med 1987;6:338

    Google Scholar 

  16. Tobias J, Houghton J, Riley DL. Moving the Goalposts–a review of clinical trial strategies in early breast cancer. In Breast Cancer–New Horizons in Research and Treatment, Chapter 17, London, Arnold, 2001;195–202

  17. Early Breast Cancer Trialists Collaborative Group. Treatment of early breast cancer. Vol I: Worldwide Evidence, 1985–1990, Oxford and New York, Oxford University Press, 1990

  18. Early Breast Cancer Trialists’ Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy: 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992;339:1–15, 71–85

    Google Scholar 

  19. Begg CB. A measure to aid in the interpretation of publicized clinical trials. Stat Med 1985;4:1

    PubMed  CAS  Google Scholar 

  20. Collins R, Gray R, Godwin J, et al. Avoidance of large biases and large random errors in assessment of moderate treatment effects: the need for systematic overviews. Stat Med 1987;2:245

    Google Scholar 

  21. Gelber RD, Goldhirsch A. The concept of an overview of cancer clinical trials with special emphasis on early breast cancer. J Clin Oncol 1986;4:1696–1703

    PubMed  CAS  Google Scholar 

  22. Demets D. Methods for combining randomized clinical trials: strengths and limitations. Stat Med 1987;6:341–348

    PubMed  CAS  Google Scholar 

  23. Simon R. The role of overviews in cancer therapeutics. Stat Med 1987;6:389–393

    PubMed  CAS  Google Scholar 

  24. Simes RJ. Publication bias: the case for an international registry of clinical trials. J Clin Oncol 1986;4:1529

    PubMed  CAS  Google Scholar 

  25. Tippett LHC. The Method of Statistics, London, Williams and Norgate, 1931

    Google Scholar 

  26. Fisher RA. Statistical Methods for Research Workers, 4th edn, London, Oliver and Boyd, 1932

    Google Scholar 

  27. Pearson K. On a method of determining whether a sample of given size n supposed to have been drawn from a parent population having a known probability integral has probably been drawn at random. Biometrika 1933;25:379

    Article  Google Scholar 

  28. Fisher RA. Combining independent test of significance. Am Stat 1948;2:30

    Article  Google Scholar 

  29. Dersimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177

    Article  PubMed  CAS  Google Scholar 

  30. May GS, Eberlein K, Furberg G, et al. Secondary prevention trials after myocardial infarction: a review. Prog Cardiovasc Dis 1982;24:331–352

    Article  PubMed  CAS  Google Scholar 

  31. Yusuf S, Peto R, Lewis J. et al. Beta-blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985;27:335–371

    PubMed  CAS  Google Scholar 

  32. Yusuf S, Collins R, Peto R, et al. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomised controlled trials. Eur Heart J 1985;6:556–585

    PubMed  CAS  Google Scholar 

  33. The 2000 EBCTCG overview: a widening gap. Comment. Lancet 2005;365:1665–1666

  34. Wittes RE. Problems in the medical interpretation of overviews. Stat Med 1987;6:269

    PubMed  CAS  Google Scholar 

  35. Berlin JA, Laird NM, Sacks HS, et al. A comparison of statistical methods for combining event rates from clinical trials. Stat Med 1989;8:141

    PubMed  CAS  Google Scholar 

  36. Lau J, Antman EM, Jimenez-Silva J, et al. Cumulative meta-analysis of therapeutic trials for myocardial infarction. JAMA 1992;268:240–248

    Article  PubMed  Google Scholar 

  37. Early Breast Cancer Trialists Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15 year survival: an overview of the randomized trials. Lancet 2005;365:1687–1717

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cambridge Breast Unit, Addenbrooke’s Hospital, Hills Road, Cambridge, CB2 2QQ, United Kingdom

    J. R. Benson MA, DM

  2. Department of Surgery, Addenbrooke’s Hospital, Hills Road, Cambridge, CB2 2QQ, United Kingdom

    K. Saeb-Parsy MA, PhD

Authors
  1. J. R. Benson MA, DM
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Saeb-Parsy MA, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. R. Benson MA, DM.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Benson, J.R., Saeb-Parsy, K. Meta-analyses in Cancer Clinical Trials: Principles and Pitfalls. World J. Surg. 30, 1177–1183 (2006). https://doi.org/10.1007/s00268-006-0081-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-006-0081-x

Keywords

Search

Navigation